@article{20675d861b9449288eb8a62da7834618,
title = "Antibody Prevalence in Epilepsy and Encephalopathy score: Increased specificity and applicability",
keywords = "autoimmune limbic encephalitis, diagnosis, epilepsy, immunotherapy, paraneoplastic limbic encephalitis, predictive model",
author = "Divyanshu Dubey and Pittock, {Sean J.} and Andrew McKeon",
note = "Funding Information: D.D. has no conflicts of interest to report. S.J.P. and Mayo Clinic have a financial interest in patents (#12/678,350 filed 2010 and #12/573,942 filed 2008) that relate to functional AQP4/NMO‐IgG assays and NMO‐IgG as a cancer marker. S.J.P. has provided consultation to Alexion Pharmaceuticals, Medimmune, and Chugai Pharma USA but has received no personal fees or personal compensation for these consulting activities. All compensation for consulting activities is paid directly to Mayo Clinic. S.J.P. has received a research grant from Alexion Pharmaceuticals for an investigator‐initiated study as well as support from the National Institutes of Health (RO1 NS065829‐01) and the Guthy Jackson Charitable Foundation for neuromyelitis optica research. A.M. has received research support from MedImmune and Euroimmun. We confirm that we have read the Journal{\textquoteright}s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.",
year = "2019",
month = feb,
doi = "10.1111/epi.14649",
language = "English (US)",
volume = "60",
pages = "367--369",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",
number = "2",
}